Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder



Status:Completed
Conditions:Overactive Bladder
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 80
Updated:4/21/2016
Start Date:May 2007
End Date:April 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The purpose of this study is to assess the safety and effectiveness of botulinum toxin type
A in treating overactive bladder in spinal cord injury or multiple sclerosis patients


Inclusion Criteria:

- Urinary incontinence as a result of neurogenic overactive bladder due to spinal cord
injury or multiple sclerosis

- Inadequate response to anticholinergic medication used to treat overactive bladder

Exclusion Criteria:

- History or evidence of pelvic or urologic abnormality

- Previous or current diagnosis of bladder or prostate cancer

- Urinary tract infection at time of enrollment
We found this trial at
2
sites
Clinical Trial Facility in Rio de Janeiro
Rio de Janeiro,
?
mi
from
Rio de Janeiro,
Click here to add this to my saved trials
Clinical Trial Facility in Middlebury Connecticut
Middlebury, Connecticut 06762
?
mi
from
Middlebury, CT
Click here to add this to my saved trials